USA Pharma News | Healthcare News 2/4

BMS’ and bluebird bio’s Abecma approved by US FDA; first CAR T cell therapy for multiple myeloma

ipharmaservices

Mar 28, 2021

Novartis’ blockbuster Entresto received the US FDA approval for a broader target population

ipharmaservices

Feb 21, 2021

US FDA approved BMS gene therapy Breyanzi

ipharmaservices

Feb 8, 2021

Merck and Bayer announced the US FDA approval for Verquvo

ipharmaservices

Jan 21, 2021

Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio

ipharmaservices

Jan 12, 2021

Biogen initiated Phase 4 trial to determine the efficacy of Spinraza in Zolgensma treated patients

ipharmaservices

Jan 12, 2021

REGENERON'S INMAZEB FIRST PRODUCT TO RECEIVE FDA APPROVAL FOR TREATING EBOLA VIRUS

ipharmaservices

Oct 18, 2020

FDA approved GSK’s Nucala for Hypereosinophilic Syndrome

ipharmaservices

Sep 26, 2020

J&J has initiated the Phase 3 clinical trial of the COVID-19 vaccine

ipharmaservices

Sep 26, 2020

Pfizer received the approval of Xalkori for ALK-positive anaplastic large cell lymphoma

ipharmaservices

Sep 24, 2020

FDA approved Trelegy Ellipta for asthma, GSK’s triple therapy is now available for asthma and COPD

ipharmaservices

Sep 10, 2020

Oxford vaccine trials were paused because of safety concerns; AZ said it’s ‘routine’

ipharmaservices

Sep 9, 2020

FDA extended emergency use authorization of Veklury to all hospitalized patients

ipharmaservices

Aug 30, 2020

FDA has provided emergency use authorization for Abbott’s easy-to-use COVID-19 antigen test

ipharmaservices

Aug 27, 2020

FDA issued Emergency Use Authorization of Convalescent Plasma for COVID-19 treatment

ipharmaservices

Aug 25, 2020

Johnson and Johnson acquired Momenta Pharmaceuticals, aims to strength immunology profile

ipharmaservices

Aug 23, 2020

Amgen’s Kyprolis and Janssen’s Darzalex combination approved by the US FDA for multiple myeloma

ipharmaservices

Aug 22, 2020

Novartis Kesimpta approved for relapsing multiple sclerosis in the US

ipharmaservices

Aug 21, 2020

FDA says no to Gilead’s most anticipated product filgotinib

ipharmaservices

Aug 19, 2020

Genentech’s Enspryng approved for Neuromyelitis Optica Spectrum Disorder in the US

ipharmaservices

Aug 15, 2020

iPharmaCenter

ipharmacenter Consulting services

BMS’ and bluebird bio’s Abecma approved by US FDA; first CAR T cell therapy for multiple myeloma

Novartis’ blockbuster Entresto received the US FDA approval for a broader target population

US FDA approved BMS gene therapy Breyanzi

Merck and Bayer announced the US FDA approval for Verquvo

Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio

Biogen initiated Phase 4 trial to determine the efficacy of Spinraza in Zolgensma treated patients

REGENERON'S INMAZEB FIRST PRODUCT TO RECEIVE FDA APPROVAL FOR TREATING EBOLA VIRUS

FDA approved GSK’s Nucala for Hypereosinophilic Syndrome

J&J has initiated the Phase 3 clinical trial of the COVID-19 vaccine

Pfizer received the approval of Xalkori for ALK-positive anaplastic large cell lymphoma

FDA approved Trelegy Ellipta for asthma, GSK’s triple therapy is now available for asthma and COPD

Oxford vaccine trials were paused because of safety concerns; AZ said it’s ‘routine’

FDA extended emergency use authorization of Veklury to all hospitalized patients

FDA has provided emergency use authorization for Abbott’s easy-to-use COVID-19 antigen test

FDA issued Emergency Use Authorization of Convalescent Plasma for COVID-19 treatment

Johnson and Johnson acquired Momenta Pharmaceuticals, aims to strength immunology profile

Amgen’s Kyprolis and Janssen’s Darzalex combination approved by the US FDA for multiple myeloma

Novartis Kesimpta approved for relapsing multiple sclerosis in the US

FDA says no to Gilead’s most anticipated product filgotinib

Genentech’s Enspryng approved for Neuromyelitis Optica Spectrum Disorder in the US